$11.64
Last update: Nov 17, 4:00 PM
Comments
Loading...
Cross Country Healthcare Stock Guidance | NASDAQ:CCRN | Benzinga
Cross Country Healthcare issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/06/2024 | CCRN | Cross Country Healthcare | Q4 | 2024 | $0.10 | $0.14 | $0.13 | $300.00M | $310.00M | $319.11M | |
07/31/2024 | CCRN | Cross Country Healthcare | Q3 | 2024 | $0.08 | $0.12 | $0.16 | $305.00M | $315.00M | $328.24M | |
05/01/2024 | CCRN | Cross Country Healthcare | Q2 | 2024 | $0.10 | $0.20 | $0.18 | $330.00M | $340.00M | $362.51M | |
02/21/2024 | CCRN | Cross Country Healthcare | Q1 | 2024 | $0.15 | $0.25 | $0.30 | $370.00M | $380.00M | $399.04M | |
11/01/2023 | CCRN | Cross Country Healthcare | Q4 | 2023 | $0.25 | $0.35 | $0.45 | $400.00M | $410.00M | $439.21M | |
08/02/2023 | CCRN | Cross Country Healthcare | Q3 | 2023 | $0.35 | $0.45 | $0.50 | $440.00M | $450.00M | $465.46M | |
05/03/2023 | CCRN | Cross Country Healthcare | Q2 | 2023 | $0.55 | $0.65 | $0.75 | $530.00M | $540.00M | $553.92M | |
02/22/2023 | CCRN | Cross Country Healthcare | Q1 | 2023 | $0.70 | $0.80 | $0.76 | $590.00M | $600.00M | $574.38M | |
11/02/2022 | CCRN | Cross Country Healthcare | Q4 | 2022 | $0.85 | $0.95 | $0.74 | $590.00M | $600.00M | $544.79M | |
09/14/2022 | CCRN | Cross Country Healthcare | FY | 2023 | — | — | — | $2.20B | — | $2.07B | |
09/14/2022 | CCRN | Cross Country Healthcare | Q4 | 2022 | — | — | — | $550.00M | — | $519.55M | |
09/14/2022 | CCRN | Cross Country Healthcare | Q3 | 2022 | $0.90 | $1.00 | $0.91 | $615.00M | $625.00M | $610.51M | |
08/03/2022 | CCRN | Cross Country Healthcare | Q3 | 2022 | $0.85 | $0.95 | $0.91 | $605.00M | $615.00M | $587.10M | |
05/04/2022 | CCRN | Cross Country Healthcare | Q2 | 2022 | $1.30 | $1.40 | $0.90 | $735.00M | $745.00M | $608.32M | |
02/23/2022 | CCRN | Cross Country Healthcare | Q1 | 2022 | $1.38 | $1.48 | $0.63 | $740.00M | $750.00M | $478.87M | |
01/19/2022 | CCRN | Cross Country Healthcare | FY | 2021 | $3.03 | $3.03 | $2.76 | $1.67B | $1.67B | $1.62B | |
01/19/2022 | CCRN | Cross Country Healthcare | Q4 | 2021 | $1.32 | $1.42 | $1.10 | $630.00M | $640.00M | $587.14M |
FAQ
What is the most recent guidance for Cross Country Healthcare (CCRN)?
The most recent guidance for Cross Country Healthcare (CCRN) was reported on November 6, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $0.10 to $0.14, compared to the estimated EPS of $0.13. Additionally, Cross Country Healthcare forecasted revenue between $0.30B and $0.31B for the quarter.
Browse guidance and forecast on all stocks.
